Advance your oncology pipeline with radiopharmaceutical innovation
Radiopharmaceuticals are redefining cancer treatment by combining targeted molecules with radionuclides to deliver precision therapy selectively to tumors. With the potential to repurpose existing oncology APIs and unlock new therapeutic opportunities, radiopharmaceuticals are rapidly gaining momentum. But their development presents unique scientific, operational, and regulatory complexities that must be carefully managed.
This ebook provides a clear overview of the radiopharmaceutical development journey and how expert CRO support can help you de-risk and accelerate your program, from proof of concept to the clinic.
In this ebook, you’ll find:
- Opportunities in Repurposing APIs – how to give failed or shelved molecules a new therapeutic ‘life’ in oncology
- Key Development Challenges – scientific, operational, and regulatory hurdles specific to radiopharmaceuticals
- Integrated Development Strategies – the value of end-to-end support, from bioconjugation chemistry to preclinical models and imaging
- Expert Insights – why choosing the right partner is critical to advancing radiopharmaceutical innovation